Difference between revisions 594504925 and 595618728 on enwiki

'''Zerona''' is a low-level laser device developed by Erchonia Corp. for non-invasive body slimming of the waist, hips, and thighs. It has been shown to disrupt [[adipocyte]], or fat cell, membranes causing the release of stored [[lipids]] and fatty material, in turn, promoting adipocyte collapse. The device was first introduced to the market in 2008 as an [[off-label use]] device for slimming, but later was granted 510k market clearance by the [[Food and Drug Administration]] (contracted; show full)

== Device ==
Zerona is a class II low-level laser under [[21 CFR]] 878.540. [[Low level laser therapy]] (LLLT) represents a division of [[photomedicine]] utilizing defined parameters of laser light for the treatment of a specific medical ailment.  The efficacy and safety of this subtle therapeutic approach is dependent on the [[wavelength]], [[dosage]], pulsation, and [[
Intensity (physics)|intensity]] being applied. For instance, laser therapy has exhibited a biphasic dose response revealing that too much applied energy could hamper or prevent the desired clinical outcome from transpiring.<ref name=pmc2790317>{{cite journal |pages=358–83 |doi=10.2203/dose-response.09-027.Hamblin |pmc=2790317 |title=Biphasic Dose Response in Low Level Lightherapy |year=2009 |last1=Hamblin |first1=Michael R. |last2=Carroll |first2=James D. |last3=Chen |first3=Aaron C.-H. |last4=Huang |first4=Ying-Ying |jo(contracted; show full)==External links==
*[http://www.erchonia.com/ Erchonia Corp., Official Website]

== References ==
{{reflist}}

[[Category:Laser medicine]]
[[Category:Management of obesity]]